Table 2.

Reports of trials that used ceftaroline to treat MRSA infection.

Criteria	Korczowski et al. [13]	Blumer et al. [16]
Total number of patients included, n	159	5
Patients with MRSA, n (%)	18 (11%)	1
Patients who received antibiotics prior to ceftaroline	9	1
Duration of treatment with ceftaroline, median (range)	3 days to 10 days	-
Clinical success of MRSA patients, n (%)	16/18 (89%)	1
Safety outcome	8% diarrhea 8% rash 7% vomiting 1% pruritis Serious adverse effects reported: 1 patient experienced hypersensitivity and another clostridium difficile colitis No death reported	Anemia, pruritus and vomiting